Summary: Dr. Huntington Potter, CU Anschutz Medical Campus professor and director of the <a href="http://medschool.ucdenver.edu/rmadc">Rocky Mountain Alzheimer’s Disease Center</a>, speaks with CU’s Ken McConnellogue about:<br> <br> * The drug leukine, which shows encouraging results<br> * Why Down syndrome research is important in Alzheimer’s research<br> * What the center is looking for in clinical studies<br> <br> Contribute to<a href="http://www.ucdenver.edu/academics/colleges/medicalschool/departments/neurology/clinical/rmadc/give/Pages/default.aspx"> Alzheimer’s research here</a>.<br>
